A Phase I/II Study of Cloretazine [laromustine; VNP 40101M] in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia or Richter's Syndrome
Phase of Trial: Phase I/II
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Laromustine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2005 New trial record.